Effective anxiety reduction
Bern, Monday 12 September 2016 10.00 GMT
After nearly four years of research and development, we are proud to announce that velibra, our digital therapy software for anxiety disorders, has demonstrated efficacy in a high quality randomized controlled trial. The trial’s Principal Investigator, Prof. Thomas Berger, concluded in Psychological Medicine, the journal in which results were recently published, that velibra “is effective in reducing symptomatology and in increasing psychological well-being assessed as early as 9 weeks after treatment initiation.” We thank our partners and patients who supported us on this successful research and development journey.
